Publications

1. Nakai H, Takahashi H, Wellnitz CV, Stanton ML, Takahashi N, Kawashima A. Imaging of Upper Tract Urothelial Carcinoma. Radiographics. 2024 Nov; 44 (11):e240056
   View PubMed
2. Meyer H, Sunkara R, Rothmann E, Shah A, Riaz I, Courtney KD, Armstrong AJ, Lippucci A, Naqvi SAA, Stanton ML, Beltran H, Bryce AH. The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate. Clin Genitourin Cancer. 2024 Oct; 22 (5):102172 Epub 2024 Aug 06
   View PubMed
3. Nielson KJ, Rowsey R, Dasari S, Sukov WR, Kipp BR, Raghunathan A, Whaley RD, Ebare K, Stanton ML, Reynolds JP, Sharma V, Thompson RH, Boorjian SA, Leibovich BC, Hernandez LH, Jimenez RE, Cheville JC, Gupta S. Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: A validation study. Hum Pathol. 2024 Apr; 146:57-65 Epub 2024 Apr 12
   View PubMed
4. Toesca DAS, Cheney SM, Singh P, Stanton ML, Wong WW. On Complete Clinical Response of Basal Cell Carcinoma of the Prostate After Definitive Concurrent Chemoradiation. Adv Radiat Oncol. 2024 Apr; 9 (4):101427 Epub 2023 Dec 23
   View PubMed
5. Voleti SS, Warren CJ, Parker NR, Stanton M, Khan AA, Noland SS, Punjani N. Excision of recurrent penile schwannoma with neurovascular bundle sparing: A novel surgical approach. Urol Case Rep. 2023 Sep; 50:102458 Epub 2023 June 12
   View PubMed
6. McCarthy MR, Nichols PE, Sharma V, Stanton ML, Reynolds JP, Pitel BA, Halling KC, Lohse CM, Herrera-Hernandez L, Thompson RH, Leibovich BC, Jimenez RE, Boorjian SA, Cheville JC, Gupta S. Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1, and ATRX. Arch Pathol Lab Med. 2023 Jul 01; 147(7):817-825.
   View PubMed
7. El Khoury LY, Pan X, Hlady RA, Wagner RT, Shaikh S, Wang L, Humphreys MR, Castle EP, Stanton ML, Ho TH, Robertson KD. Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome. Clin Epigenetics. 2023 Apr 29; 15 (1):71
   View PubMed
8. Janiszewski RA, Pham M, Stanton ML, Nguyen BD. Imaging and pathologic correlation of composite pheochromocytoma-ganglioneuroma. Jpn J Clin Oncol. 2023 Apr 29; 53 (5):452-453
   View PubMed
9. Sykora D, Chaliki HP, Cummings KW, Sell-Dottin K, Stanton ML, Scott LR. Incidentally Discovered Right Atrial Mass: A Rare and Unexpected Etiology. Tex Heart Inst J. 2023 Mar 1; 50 (2)
   View PubMed
10. Gupta S, Stanton ML, Reynolds JP, Whaley RD, Herrera-Hernandez L, Jimenez RE, Cheville JC. Reprint of: lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas & renal cell carcinoma. Hum Pathol. 2023 Mar; 133:136-152 Epub 2023 Mar 07
    View PubMed
11. Hoegger MJ, Strnad BS, Ballard DH, Siegel CL, Shetty AS, Weimholt RC, Yano M, Stanton ML, Mellnick VM, Kawashima A, Zulfiqar M. Urinary Bladder Masses, Rare Subtypes, and Masslike Lesions: Radiologic-Pathologic Correlation. Radiographics. 2023 Jan; 43 (1):e220034
    View PubMed
12. Gupta S, Stanton ML, Reynolds JP, Whaley RD, Herrera-Hernandez L, Jimenez RE, Cheville JC. Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma. Hum Pathol. 2022 Nov; 129:123-139 Epub 2022 Sept 14
    View PubMed
13. Gupta S, Folpe AL, Torres-Mora J, Reuter VE, Zuckerman JE, Falk N, Stanton ML, Muthusamy S, Smith SC, Sharma V, Sethi S, Herrera-Hernandez L, Jimenez RE, Cheville JC. Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumors. Hum Pathol. 2022 Oct; 128:110-123 Epub 2022 Aug 01
    View PubMed
14. Pham M, Janiszewski RA, Stanton ML, Nguyen BD. Renal transplants with perinephric myxoid pseudotumor of fat mimicking malignancy. Jpn J Clin Oncol. 2022 May 31; 52 (6):654-655
    View PubMed
15. Faraj KS, Judge N, Chang YH, Blodgett G, Stanton ML, Tyson MD. Variation in Lymph Node Yield After Radical Cystectomy. Am J Clin Pathol. 2021 Aug 4; 156 (3):391-398
    View PubMed
16. Kriegshauser JS, Dahiya N, Smith ML, Zhang N, Heilman RL, Stanton ML, Young SW, Patel MD. Added Benefit and Risk of an Additional Biopsy or Targeting With Contrast-Enhanced Ultrasound for Patients With Renal Transplants. J Ultrasound Med. 2021 Aug; 40 (8):1603-1611 Epub 2020 Oct 26
    View PubMed
17. Yakirevich E, Pavlick DC, Perrino CM, Stanton M, Lu S, Carneiro B, Bratslavsky G, Ross JS. NF2 Tumor Suppressor Gene Inactivation in Advanced Papillary Renal Cell Carcinoma. Am J Surg Pathol 2021 May 1; 45 (5):716-718
    View PubMed
18. El Khoury LY, Fu S, Hlady RA, Wagner RT, Wang L, Eckel-Passow JE, Castle EP, Stanton ML, Thompson RH, Parker AS, Ho TH, Robertson KD. Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer. Clin Epigenetics. 2021 Jan 18; 13 (1):12
    View PubMed
19. Nevo A, Muchtar E, Stern KL, Moore JP, Cheney SM, Humphreys MR, Grogan M, Stanton ML. The Clinical Implication of Incidental Prostatic Amyloidosis. Urology. 2020 Nov; 145:253-257 Epub 2020 Sept 19
    View PubMed
20. Wilson MR, Holladay J, Sheridan R, Hostetter G, Berghuis B, Graveel C, Essenburg C, Peck A, Ho TH, Stanton M, Chandler RL. Lgr5-positive endothelial progenitor cells occupy a tumor and injury prone niche in the kidney vasa recta. Stem Cell Res. 2020 Jul; 46:101849 Epub 2020 May 20
    View PubMed
21. Parra LA, Stanton ML, Nguyen BD. Urothelial cancer of the uretero-vesical junction on (18)F-Fluciclovine PET/CT. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 May - Jun; 39 (3):180-181 Epub 2020 Jan 09
    View PubMed
22. Glinsmann-Gibson B, Wisner L, Stanton M, Larsen B, Rimsza L, Maguire A. Recommendations for Tissue Microarray Construction and Quality Assurance. Appl Immunohistochem Mol Morphol. 2020 Apr; 28 (4):325-330
    View PubMed
23. Barrett MT, Lenkiewicz E, Malasi S, Stanton M, Slack J, Andrews P, Pagliaro L, Bryce AH. Clonal analyses of refractory testicular germ cell tumors. PLoS One. 2019; 14 (3):e0213815 Epub 2019 Mar 14
    View PubMed
24. Kocher JP, Sun Q, Wu Y, Miller M, Zhang W, Wang J, Zhang J, Wong T, Lee S, Zhao F, Anderson ML, Brat DJ, Olson JJ, Sica G, Ahn K, Bell D, Borad M, Bryce AH, Castle E, Chandan V, Cheville J, Copland JA, Farnell M, Flotte T, Giama N, Ho T, Nagorney D, O'Brien D, O'Neill BP, Patel T, Petersen G, Que F, Rivera M, Roberts L, Smallridge R, Smyrk T, Stanton M, Thompson RH, Torbenson M, Zhang L, Guo C, Haydu L, Quinn M, Dhanasekaran R, Nguyen P, Peterson L, Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS, Liu Y, Akbani R, Feng B, Donehower LA, Miller C, Shen Y, Karimi M, Chen H, Kim P, Jia P, Shinbrot E, Zhang S, Liu J, Hu H, Bailey MH, Yau C, Wolf D, Zhao Z, Weinstein JN, Li L, Ding L, Mills GB, Laird PW, Wheeler DA, Shmulevich I, Monnat RJ Jr, Xiao Y, Wang C, Cancer Genome Atlas Research Network. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep. 2018 Apr 3; 23 (1):239-254.e6
    View PubMed
25. Ferdosi S, Ho TH, Castle EP, Stanton ML, Borges CR. Behavior of blood plasma glycan features in bladder cancer. PLoS One. 2018; 13 (7):e0201208 Epub 2018 July 24
    View PubMed
26. Abdul-Muhsin HM, Jakob NJ, Kawashima A, Silva AC, Stanton ML, Moshero G, Castle EP, Andrews PE, Humphreys MR. Natural Orifice Transluminal Endoscopic Partial Prostatectomy: A Real-time Image-guided Focal Extirpative Feasibility Study. Urology. 2017 Sep; 107:262-266 Epub 2017 May 24
    View PubMed
27. Bryce AH, Borad MJ, Egan JB, Condjella RM, Liang WS, Fonseca R, McCullough AE, Hunt KS, Ritacca NR, Barrett MT, Patel MD, Young SW, Silva AC, Ho TH, Halfdanarson TR, Stanton ML, Cheville J, Swanson S, Schneider DE, McWilliams RR, Baker A, Aldrich J, Kurdoglu A, Izatt T, Christoforides A, Cherni I, Nasser S, Reiman R, Cuyugan L, McDonald J, Adkins J, Mastrian SD, Von Hoff DD, Craig DW, Stewart AK, Carpten JD. Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib. Clin Genitourin Cancer. 2017 Aug; 15 (4):e727-e734 Epub 2016 Dec 01
    View PubMed
28. Ho TH, Nunez-Nateras R, Hou YX, Bryce AH, Northfelt DW, Dueck AC, Wong B, Stanton ML, Joseph RW, Castle EP. A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer. Clin Genitourin Cancer. 2017 Apr; 15 (2):196-202.e1 Epub 2016 Sept 08
    View PubMed
29. Stanton M. The First Mayo Clinic Pathology Update: Selected Topics in Surgical Pathology. Arch Pathol Lab Med. 2017 Feb; 141: (2)222.
    View PubMed
30. Adike A, Boppana V, Lam-Himlin D, Stanton M, Nelson S, Ruff KC. A Mysterious DRESS Case: Autoimmune Enteropathy Associated with DRESS Syndrome. Case Rep Gastrointest Med. 2017; 2017:7861857 Epub 2017 Nov 26
    View PubMed
31. Stanton M. The first Mayo Clinic pathology update Archives of Pathology & Laboratory Medicine. 2017; 141: (2)222.
    
32. Parasramka M, Serie DJ, Asmann YW, Eckel-Passow JE, Castle EP, Stanton ML, Leibovich BC, Thompson RH, Thompson EA, Parker AS, Ho TH, Joseph RW. Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death. Eur Urol Focus. 2016 Dec 15; 2 (6):608-615 Epub 2016 Apr 02
    View PubMed
33. Zhu P, Stanton ML, Castle EP, Joseph RW, Adams DL, Li S, Amstutz P, Tang CM, Ho TH. Detection of tumor-associated cells in cryopreserved peripheral blood mononuclear cell samples for retrospective analysis. J Transl Med. 2016 Jul 2; 14 (1):198 Epub 2016 July 02
    View PubMed
34. Fay AP, de Velasco G, Ho TH, Van Allen EM, Murray B, Albiges L, Signoretti S, Hakimi AA, Stanton ML, Bellmunt J, McDermott DF, Atkins MB, Garraway LA, Kwiatkowski DJ, Choueiri TK. Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma. J Natl Compr Canc Netw. 2016 Jul; 14 (7):820-4
    View PubMed
35. Ho TH, Choueiri TK, Wang K, Karam JA, Chalmers Z, Frampton G, Elvin JA, Johnson A, Liu X, Lin Y, Joseph RW, Stanton ML, Miller VA, Stephens PJ, Ross JS, Ali SM, Pal SK. Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response. Eur Urol Focus. 2016 Jun; 2 (2):204-209 Epub 2015 Dec 09
    View PubMed
36. Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AA, Shinbrot E, Sethi A, Brooks S, Rathmell WK, Brooks AN, Hoadley KA, Robertson AG, Brooks D, Bowlby R, Sadeghi S, Shen H, Weisenberger DJ, Bootwalla M, Baylin SB, Laird PW, Cherniack AD, Saksena G, Haake S, Liang H, Lu Y, Mills GB, Akbani R, Leiserson MD, Raphael BJ, Anur P, Bottaro D, Albiges L, Barnabas N, Choueiri TK, Czerniak B, Godwin AK, Hakimi AA, Ho TH, Hsieh J, Ittmann M, Kim WY, Krishnan B, Merino MJ, Mills Shaw KR, Reuter VE, Reznik E, Shelley CS, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Tickoo S, Burnett K, Crain D, Gardner J, Lau K, Mallery D, Morris S, Paulauskis JD, Penny RJ, Shelton C, Shelton WT, Sherman M, Thompson E, Yena P, Avedon MT, Bowen J, Gastier-Foster JM, Gerken M, Leraas KM, Lichtenberg TM, Ramirez NC, Santos T, Wise L, Zmuda E, Demchok JA, Felau I, Hutter CM, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang J, Ayala B, Baboud J, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan Y, Wu Y, Ally A, Balasundaram M, Balu S, Beroukhim R, Bodenheimer T, Buhay C, Butterfield YS, Carlsen R, Carter SL, Chao H, Chuah E, Clarke A, Covington KR, Dahdouli M, Dewal N, Dhalla N, Doddapaneni HV, Drummond JA, Gabriel SB, Gibbs RA, Guin R, Hale W, Hawes A, Hayes DN, Holt RA, Hoyle AP, Jefferys SR, Jones SJ, Jones CD, Kalra D, Kovar C, Lewis L, Li J, Ma Y, Marra MA, Mayo M, Meng S, Meyerson M, Mieczkowski PA, Moore RA, Morton D, Mose LE, Mungall AJ, Muzny D, Parker JS, Perou CM, Roach J, Schein JE, Schumacher SE, Shi Y, Simons JV, Sipahimalani P, Skelly T, Soloway MG, Sougnez C, Tam A, Tan D, Thiessen N, Veluvolu U, Wang M, Wilkerson MD, Wong T, Wu J, Xi L, Zhou J, Bedford J, Chen F, Fu Y, Gerstein M, Haussler D, Kasaian K, Lai P, Ling S, Radenbaugh A, Van Den Berg D, Weinstein JN, Zhu J, Albert M, Alexopoulou I, Andersen JJ, Auman JT, Bartlett J, Bastacky S, Bergsten J, Blute ML, Boice L, Bollag RJ, Boyd J, Castle E, Chen YB, Cheville JC, Curley E, Davies B, DeVolk A, Dhir R, Dike L, Eckman J, Engel J, Harr J, Hrebinko R, Huang M, Huelsenbeck-Dill L, Iacocca M, Jacobs B, Lobis M, Maranchie JK, McMeekin S, Myers J, Nelson J, Parfitt J, Parwani A, Petrelli N, Rabeno B, Roy S, Salner AL, Slaton J, Stanton M, Thompson RH, Thorne L, Tucker K, Weinberger PM, Winemiller C, Zach LA, Zuna R, Cancer Genome Atlas Research Network. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14; 374: (2)135-45.
    View PubMed
37. Ho TH, Kapur P, Joseph RW, Serie DJ, Eckel-Passow JE, Tong P, Wang J, Castle EP, Stanton ML, Cheville JC, Jonasch E, Brugarolas J, Parker AS. Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death. Mod Pathol. 2016 Jan; 29 (1):34-42 Epub 2015 Oct 30
    View PubMed
38. Joseph RW, Millis SZ, Carballido EM, Bryant D, Gatalica Z, Reddy S, Bryce AH, Vogelzang NJ, Stanton ML, Castle EP, Ho TH. PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation. Cancer Immunol Res. 2015 Dec; 3 (12):1303-7 Epub 2015 Aug 25
    View PubMed
39. Ho TH, Nateras RN, Yan H, Park JG, Jensen S, Borges C, Lee JH, Champion MD, Tibes R, Bryce AH, Carballido EM, Todd MA, Joseph RW, Wong WW, Parker AS, Stanton ML, Castle EP. A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona. PLoS One. 2015; 10 (7):e0132831 Epub 2015 July 16
    View PubMed
40. Choueiri TK, Fay AP, Gray KP, Callea M, Ho TH, Albiges L, Bellmunt J, Song J, Carvo I, Lampron M, Stanton ML, Hodi FS, McDermott DF, Atkins MB, Freeman GJ, Hirsch MS, Signoretti S. PD-L1 expression in nonclear-cell renal cell carcinoma. Ann Oncol. 2014 Nov; 25 (11):2178-2184 Epub 2014 Sept 05
    View PubMed
41. Asaki HE, Moshero G, Stanton ML, Humphreys MR. Xp11.2 translocation tumor: a rare cause of gross hematuria. JAAPA. 2014 Feb; 27(2):24-7.
    View PubMed
42. Hakim FA, Singh S, Pandit A, Alegria JR, Camoriano J, Stanton ML, Mookadam F. Interferon-alpha and pericardial injury: a case report and literature review. Heart Asia. 2014; 6 (1):48-53 Epub 2014 Apr 16
    View PubMed
43. Nunez-Nateras R, Castle EP, Protheroe CA, Stanton ML, Ocal TI, Ferrigni EN, Ochkur SI, Jacobsen EA, Hou YX, Andrews PE, Colby TV, Lee NA, Lee JJ. Predicting response to bacillus Calmette-Guerin (BCG) in patients with carcinoma in situ of the bladder. Urol Oncol. 2014 Jan; 32 (1):45.e23-30 Epub 2013 Sept 18
    View PubMed
44. Stanton ML, Xiao L, Czerniak BA, Guo CC. Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases. Arch Pathol Lab Med. 2013 Oct; 137(10):1337-41.
    View PubMed
45. Wisenbaugh ES, Stanton ML, Grimsby GM, Tyson MD, Castle EP. Metastatic malignant melanoma to the bladder: a case series. Curr Urol. 2012 May; 6 (1):53-6 Epub 2012 Apr 30
    View PubMed
46. Si Q, Dancer J, Stanton ML, Tamboli P, Ro JY, Czerniak BA, Shen SS, Guo CC. Small cell carcinoma of the kidney: a clinicopathologic study of 14 cases. Hum Pathol. 2011 Nov; 42(11):1792-8.
    View PubMed
47. Dhingra S, Rodriguez ME, Shen Q, Duan X, Stanton ML, Chen L, Zhang R, Brown RE. Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications. Int J Clin Exp Pathol. 2011; 4(2):134-46. Epub 2010 Jan 28.
    View PubMed
48. Shen Q, Stanton ML, Feng W, Rodriguez ME, Ramondetta L, Chen L, Brown RE, Duan X. Morphoproteomic Analysis Reveals an Overexpressed and Constitutively Activated Phospholipase D1-mTORC2 Pathway in Endometrial Carcinoma. International Journal of Clinical and Experimental Pathology. 2011; 4(1).
    
49. Shen Q, Stanton ML, Feng W, Rodriguez ME, Ramondetta L, Chen L, Brown RE, Duan X. Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma. Int J Clin Exp Pathol. 2010; 4(1):13-21. Epub 2010 Nov 20.
    View PubMed